A new FirstWord report takes a deep dive into the payer’s perspective on specialized cancer treatments to reveal how pharmaceutical companies can garner payer support.
The report, “Pricing and Reimbursement in Oncology: Payer Views,” includes insights from eight experienced U.S. and European payers.
“To achieve formulary position and the widest possible prescribing, pharma needs payers positively on board, so what practical steps can developers take to get payer support for their oncology product’s pricing and reimbursement ambitions?” a description of the report states.
To learn more about this report, click here.
